Jan. 11, 2021
MEDELPHARM, the global leader in the development of compaction simulator technology, has announced a strategic partnership with KORSCH AG – the global leader in tablet press technology, offering solutions for product development, scale-up, high-speed production, multi-layer, mini-tablet, and WIP/high-containment applications – to introduce a new portfolio of equipment geared to R&D stage production.
The collaboration includes a joint microsite dedicated to the new R&D lineup: www.r-d-in-focus.com.
Lyon, France - MEDELPHARM, the global leader in the development of compaction simulator technology, has announced a strategic partnership with KORSCH AG – the global leader in tablet press technology, offering solutions for product development, scale-up, high-speed production, multi-layer, mini-tablet, and WIP/high-containment applications – to introduce a new portfolio of equipment geared to R&D stage production. The collaboration includes a joint microsite dedicated to the new R&D lineup: www.r-d-in-focus.com.
Leveraging the companies’ combined 125-plus years of experience with small-scale, fully instrumented machines, the R&D product portfolio addresses and overcomes longstanding challenges, from early stage powder characterization and formulation development to scale-up and production support. The combined KORSCH-MEDELPHARM R&D product equipment lineup includes:
Covering the full spectrum of tableting technology from single-layer to five-layer as well as core coating capabilities, the new R&D product equipment portfolio serves as a versatile complement to KORSCH’s multilayer production machinery. Notably, the STYL’One Evo offers the ability to simulate all high-speed productionpresses to predict product performance with minimal material quantities.
Like the MEDELPHARM Science Laboratory in Lyon, France, the KORSCH Innovation Centers in Berlin and Boston have installed the STYL’One Evo and STYL’One Nano machines for demonstration, testing and, by simulating the full range of KORSCH production equipment, product trials with predictive results. The facilities in Lyon and Berlin also are offering contract services including formulation optimization, powder analysis, and material characterization.
MEDELPHARM is the designer and proprietor of STYL’One hardware and software technology. Under the agreement, MEDELPHARM equipment and software will continue to be designed, developed, and manufactured in Lyon, France. With an existing global customer base of nearly 200 machines, MEDELPHARM STYL’One technology will be supported by the KORSCH global technical service network with OEM spare part inventories in Berlin and Boston.
To support worldwide distribution, KORSCH will offer the fully combined R&D product equipment lineup on a global basis with the exception of France and Belgium. In those countries, MEDELPHARM has exclusive rights to distribute the new line, as well as the full range of KORSCH production equipment, in addition to its current representation of LB Bohle and other complementary technology brands.
About KORSCH AG
Founded in 1919 in Berlin, Germany, KORSCH AG has a 100-year tradition and commitment to innovation. As the only true specialist in the tablet press market, KORSCH focuses solely and completely on the advancement of tablet press technology for pharmaceutical, nutraceutical, food, confectionary, technical, and chemical products.
The result is generations of experience developing the broadest, most innovative tableting equipment portfolio in the world. In operation worldwide, KORSCH tablet presses are supported by a global network of sales and technical service specialists.
For more information, visit www.korsch.com
Founded in 1985 in Lyon, France, MEDELPHARM has over 35 years of experience in the tableting sector. Among other initiatives, the precision engineering company designs and manufactures research & development compaction simulators, and provides innovative solutions for powder analysis and formulation support.
Staffed by a dedicated team of scientists and technicians, the MEDELPHARM Science Lab performs trials with predictive results and supports its customers with formulation and powder characterization challenges. In addition, MEDELPHARM Distribution also represents a range of solutions in powder processing, from R&D to production.
For more information, visit: www.medelpharm.com